The time is uncertain. Generally speaking, in China, it takes about 180 to 240 working days to complete the review from the date when the application for listing of new drugs and related materials are sent to National Medical Products Administration Evaluation Center and the acceptance notice is obtained, and the monitoring period of new drugs is also required.

Regarding the registration of new drugs, China also stipulates that before applying for drug registration, applicants should complete relevant research work such as pharmacy, pharmacology, toxicology and clinical trials of drugs. To apply for drug registration, true, sufficient and reliable data, materials and samples shall be provided to prove the safety, effectiveness and quality controllability of drugs.